Jonathan Peter Boltax, MD
Pulmonary Disease Physician · Jackson, WY
Jonathan Peter Boltax, MD is a pulmonary disease physician with a practice address in Jackson, Wyoming, and NPI 1629023692, issued on May 24, 2006. Check the license (Wyoming 9935A, as entered in NPPES) on the Wyoming Board of Medicine; the Medicare figures below come from public CMS files.
- Name
- Jonathan Peter Boltax
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 9935A WY
Self-reported in NPPES; status is on the state search - Practice location
- 555 E Broadway Ave Ste 220, Jackson, WY 83001
- Phone
- (307) 739-7305
- Enumerated
- May 24, 2006
- Record last updated
- Jan 4, 2024
- Fax
- (307) 739-4960
- Medicaid ID
- 121002500 WY
- Medicare enrollment
- Enrolled (PECOS I20150324002473); accepts Medicare assignment
- Medical or professional school
- Temple University School Of Medicine, 2002
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 11 in Wyoming → Look up another NPI →
Also registered at 555 E Broadway Ave Ste 220
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Christine HoultonAmbulatory Care Registered Nurse1144780560
Verify Jonathan Peter Boltax in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWyoming Board of Medicine
Search for license 9935ACheck the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
59% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
589 Medicare Part D claims for 149 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 57% of claims.
Most prescribed
- Trelegy Ellipta63 claims
- Anoro Ellipta59 claims
- Omeprazole36 claims
- Fluticasone Propionate27 claims
- Stiolto Respimat26 claims
- Azithromycin25 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $89.99
1 payment: education; the largest payer was Sanofi-Aventis U.S. LLC. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Teton County Hospital DistrictJackson, WY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Jonathan Peter Boltax among 11 pulmonary disease physician records in Wyoming
Jonathan Peter Boltax, MD is one of 11 pulmonary disease physician records with a practice address in Wyoming. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 9% of them.
- NPI issued2006 · 9% of these records are older, 36% newer
- In a Medicare fileYes · 82% of these records are
- In the CMS Doctors and Clinicians fileYes · 73% of these records are
- Record last updated2024 · 64% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Wyoming practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Wyoming
There are 11 pulmonary disease physician records in Wyoming.
All 11 in Wyoming → Every provider in Jackson → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Thomas Repas, DOGillette, WY 827161134180516
- Henry Fisher, M.D.Casper, WY 826011063517506
- Muhammad Hussieno, MDCasper, WY 826011922112531
- Jack Malone, DOCasper, WY 826011629561196
- Stephen Mainini, MDCody, WY 824141336242114
- Laura Martin, MDCheyenne, WY 820091184607152
- Manish Aggarwal, M.D.Cheyenne, WY 820011427250547
- Darryl Bindschadler, MDCheyenne, WY 820011811130289
Common questions
What is Jonathan Peter Boltax, MD's NPI number?
Jonathan Peter Boltax, MD's National Provider Identifier (NPI) is 1629023692, issued on May 24, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Jonathan Peter Boltax, MD located?
The NPPES record lists a practice address at 555 E Broadway Ave Ste 220, Jackson, WY, 83001. Phone: (307) 739-7305. Providers update this record themselves, so call before visiting.
How can I verify Jonathan Peter Boltax, MD's license?
NPPES lists Wyoming license number 9935A, as entered by the provider. Search the Wyoming Board of Medicine at https://wyomedboard.wyo.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jonathan Peter Boltax, MD prescribe under Medicare Part D?
In 2024, Jonathan Peter Boltax, MD had 589 Medicare Part D claims for 149 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.